Insider trades
Arturo Md Molina, Chief Officer of Protagonist Therapeutics PTGX, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $4.5M. The latest trade was on 03/26.
Arturo Md Molina
Chief Medical Officer
- First filing
- 23/01/18
- Trades
- 45 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$4.5M
- Last trade
- 03/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/26 | 03/27 | 15,000 sh | $104.79 | $1,571,850 | −15.1% | |
PTGX | Open-market sale | 01/23–01/27 | 01/27 | 23,151 sh3 trades | $82.30avg. | $1,905,305.42 | −21.6% |
| Open-market sale | 01/20 | 01/21 | 9,514 sh | $82.48 | $784,714.72 | −8.9% | |
| Open-market sale | 25/11/17 | 25/11/19 | 2,712 sh | $84.77 | $229,896.24 | −3.2% | |
PTGX | Open-market sale | 25/06/09–25/06/10 | 25/06/11 | 20,000 sh2 trades | $56.27avg. | $1,125,400 | −19.3% |
| Open-market sale | 25/03/13 | 25/03/14 | 30,514 sh | $55.74 | $1,700,850.36 | −26.7% | |
PTGX | Open-market sale | 25/01/16 | 25/01/17 | 3,640 sh2 trades | $0.00avg. | $0 | −4.2% |
PTGX | Open-market sale | 24/11/26–24/11/27 | 24/11/27 | 31,529 sh3 trades | $44.86avg. | $1,414,402.4 | −40.4% |
| Open-market sale | 24/11/15 | 24/11/19 | 1,906 sh | $40.98 | $78,107.88 | −3.9% | |
| Open-market sale | 23/11/15 | 24/01/04 | 1,848 sh | $16.24 | $30,011.52 | −7.6% |